Insmed (INSM) Return on Capital Employed Growth (1y) (2012 - 2026)
Insmed (INSM) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
16,829.00 |
| 10 |
Insmed |
19.79 Bn |
18.57 Bn |
258.54 Mn |
-510.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-510.00 |
| Dec 31, 2025 |
-1,719.00 |
| Sep 30, 2025 |
-838.00 |
| Jun 30, 2025 |
2,424.00 |
| Mar 31, 2025 |
2,727.00 |
| Dec 31, 2024 |
1,398.00 |
| Sep 30, 2024 |
821.00 |
| Jun 30, 2024 |
-2,714.00 |
| Mar 31, 2024 |
-4,898.00 |
| Dec 31, 2023 |
-2,413.00 |
| Sep 30, 2023 |
-1,193.00 |
| Jun 30, 2023 |
-1,353.00 |
| Mar 31, 2023 |
-134.00 |
| Dec 31, 2022 |
-745.00 |
| Sep 30, 2022 |
-1,369.00 |
| Jun 30, 2022 |
-97.00 |
| Mar 31, 2022 |
804.00 |
| Dec 31, 2021 |
508.00 |
| Sep 30, 2021 |
-404.00 |
| Jun 30, 2021 |
-646.00 |
